Contribution of serine residues to constitutive and agonist- induced signaling via the D(2S) dopamine receptor: Evidence for multiple, agonist- specific active conformations

Molecular Pharmacology

Volumn 54, Issue 2, 1998, Pages 435-444

  Wiens, Brenda L ^a,b   Nelson, Cole S ^a   Neve, Kim A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DIHYDREXIDINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; POTASSIUM CHANNEL;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CATECHOLAMINE BLOOD LEVEL; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; GENE MUTATION; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

EID: 0031871997     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.2.435     Document Type: Article

References (38)

1. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
2. Cox BA, Henningsen RA, Spanoyannis A, Neve RL, and Neve KA (1992) Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors. J Neurochem 59:627-635.
3. Dascal N (1987) The use of Xenopus oocytes for the study of ion channels. CRC Crit Rev Biochem 22:317-387.
4. s. Mol Pharmacol 45: 696-702.
5. 2 dopamine receptor activation of a potassium channel in rat lactotrophs. J Physiol 462:563-578.
6. Gardner B (1995) Molecular mechanisms of agonism: agonists determine receptor conformation and hence G protein affinity. Trends Pharmacol Sci 16:259-260.
7. i protein subtypes regulate a single effector mechanism. Mol Pharmacol 40:707-711.
8. 2 adrenergic receptor: evidence for ligand-specific conformational changes. J Biol Chem 270:28268-28275.
9. Gurwitz D, Haring R, Heldman E, Fraser CM, Manor D, and Fisher A (1994) Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands. Eur J Pharmacol 267:21-31.
10. 2 dopamine receptors. Br J Pharmacol 121:731-736.
11. 2(444) receptor and antagonist/agonist binding ratios. Br J Pharmacol 115:1307-1313.
12. 1-adrenergic receptor agonist binding and activation. J Biol Chem 271:6322-6327.
13. Kenakin T (1995) Agonist-receptor efficacy. II: Agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232-238.
14. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463.
15. + channels are activated by Gβγ subunits and function as heteromultimers. Proc Natl Acad Sci USA 92:6542-6546.
16. 1 dopamine receptor. Mol Pharmacol 52:1137-1149.
17. KACh,. J Biol Chem 270:29059-29062.
18. s complex: evidence for agonist-specific states. Mol Pharmacol 52:144-154.
19. 2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities. Mol Pharmacol 42:432-438.
20. b from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. Trends Pharmacol Sci 14:237-239.
21. Leff P, Scarborough RM, Law C, and McKechnie K (1997) A three-state receptor model of agonist action. Trends Pharmacol Sci 18:355-362.
22. 2 receptor. Eur J Pharmacol 227:205-214.
23. 2-adrenergic receptors involves multiple subsites. EMBO (Eur Mol Biol Organ) J 9:1471-1476.
24. 2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine. Neuropsychopharmacology 15:53-61.
25. Perez DM, Hwa J, Gaivin R, Mathur M, Brown F, and Graham RM (1996) Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol 49:112-122.
26. Pollock NJ, Manelli AM, Hutchins CW, Steffey ME, MacKenzie RG, and Frail DE (1992) Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. J Biol Chem 267:17780-17786.
27. Reale V, Hannan F, Hall LM, and Evans PD (1997) Agonist-specific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists. J Neurosci 17:6545-6553.
28. Robb S, Cheek TR, Hannan FL, Hall LM, Midgley JM, and Evans PD (1994) Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J 13:1325-1330.
29. 2 adrenergic receptor: extending the ternary complex model. J Biol Chem 268:4625-4636.
30. + channel, GIRK, in Xenopus oocytes. J Gen Physiol 109:477-490.
31. Shimizu H, Daly JW, and Creveling CR (1969) A radioisotopic method for measuring the formation of adenosine 3′,5′-monophosphate in incubated slices of brain. J Neurochem 16:1609-1619.
32. Strader CD, Candelore MR, Hill WS, Sigal IS, and Dixon RAF (1989) Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J Biol Chem 264:13572-13578.
33. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol 40:168-179.
34. 2 dopamine receptors. Mol Pharmacol 50:966-976.
35. 4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol Pharmacol 49:656-661.
36. Wickman KD, Iniguez-Lluhi JA, Davenport PA, Taussig R, Krapivinsky GB, Linder ME, Gilman AG, and Clapham DE (1994) Recombinant G-protein βγ-subunits activate the muscarinic-gated atrial potassium channel. Nature (Lond) 368:255-257.
37. 2 dopamine receptor using site-directed mutagenesis. J Neurochem 66:394-402.
38. 2-dopamine receptor of the anterior pituitary gland. Mol Pharmacol 26:214-227.